Dolby Laboratories, Inc. (DLB) Files Form 4 Insider Selling : Michael Bergeron Sells 50,000 Shares

Dolby Laboratories, Inc. (DLB): Michael Bergeron , SVP, WW Sales and Field Oper. of Dolby Laboratories, Inc. sold 50,000 shares on May 17, 2016. The Insider selling transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were sold at $45.02 per share for a total value of $2,250,835.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 17, 2016, Lewis Chew (EVP & Chief Financial Officer) sold 20,000 shares at $45.49 per share price.On May 16, 2016, Roger S Siboni (director) sold 13,921 shares at $45.44 per share price.Also, On May 13, 2016, Dagmar Dolby (10% owner) sold 100 shares at $41.43 per share price.On May 2, 2016, Kevin J Yeaman (President and CEO) sold 51,230 shares at $46.56 per share price.

Shares of Dolby Laboratories (DLB) ended Thursday, May 19, 2016 session in red amid volatile trading. The shares closed down -0.29 points or -0.65% at $44.24 with 2,79,164 shares getting traded. Post opening the session at $44.38, the shares hit an intraday low of $44.06 and an intraday high of $44.45 and the price vacillated in this range throughout the day. The company has a market cap of $4,436 M and the number of outstanding shares has been calculated to be 10,02,64,219 shares. The 52-week high of Dolby Laboratories is $48.7 and the 52-week low is $29.87.

Dolby Laboratories Money Flow Index Chart

Company has been under the radar of several Street Analysts.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 54 from a previous price target of $46 .The Rating was issued on Apr 28, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Apr 25, 2016.Dolby Laboratories is Downgraded by JP Morgan to Neutral. Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Apr 8, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Mar 28, 2016.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.